Literature DB >> 25261428

Toxicology and management of novel psychoactive drugs.

Brian P Kersten1, Megan E McLaughlin2.   

Abstract

Health care providers are seeing an increased number of patients under the influence of several new psychoactive drug classes. Synthetic cannabinoids, cathinones, and piperazines are sought by users for their psychoactive effects, perceived safety profile, minimal legal regulations, and lack of detection on routine urine drug screening. However, these drugs are beginning to be recognized by the medical community for their toxic effects. The neuropsychiatric and cardiovascular toxicities are among the most common reasons for emergency medical treatment, which in some cases, can be severe and even life-threatening. Management strategies are often limited to supportive and symptomatic care due to the limited published data on alternative treatment approaches. The purpose of this article is to offer health care providers, emergency medical personnel in particular, an awareness and understanding of the dangers related to some of the new psychoactive drugs of abuse. The background, pharmacology, toxicity, management, detection, and legal status of each class will be discussed.
© The Author(s) 2014.

Entities:  

Keywords:  cathinone; drug abuse; piperazine; synthetic cannabinoid; toxicity

Mesh:

Substances:

Year:  2014        PMID: 25261428     DOI: 10.1177/0897190014544814

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  7 in total

Review 1.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

2.  Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Hua Zhang; Tatyana Y Postnikova; Karina Pats; Elena Fedorova; Vladimir Poroikov; Aleksey V Zaitsev; Ilya Bezprozvanny
Journal:  Mol Pharmacol       Date:  2019-01-29       Impact factor: 4.436

Review 3.  Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.

Authors:  Cristina Miliano; Giovanni Serpelloni; Claudia Rimondo; Maddalena Mereu; Matteo Marti; Maria Antonietta De Luca
Journal:  Front Neurosci       Date:  2016-04-19       Impact factor: 4.677

4.  Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs.

Authors:  Anna Welz; Marcin Koba; Piotr Kośliński; Joanna Siódmiak
Journal:  J Clin Med       Date:  2022-03-22       Impact factor: 4.241

Review 5.  An Update on the Implications of New Psychoactive Substances in Public Health.

Authors:  Ana Y Simão; Mónica Antunes; Emanuel Cabral; Patrik Oliveira; Luana M Rosendo; Ana Teresa Brinca; Estefânia Alves; Hernâni Marques; Tiago Rosado; Luís A Passarinha; Maristela Andraus; Mário Barroso; Eugenia Gallardo
Journal:  Int J Environ Res Public Health       Date:  2022-04-17       Impact factor: 4.614

6.  A Curious Case of Inhalation Fever Caused by Synthetic Cannabinoid.

Authors:  Thiru Chinnadurai; Srijan Shrestha; Raji Ayinla
Journal:  Am J Case Rep       Date:  2016-06-05

7.  Rapid Targeted Method of Detecting Abused Piperazine Designer Drugs.

Authors:  Anna Welz; Marcin Koba; Piotr Kośliński; Joanna Siódmiak
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.